Do NSAIDs Take Us Away From Treatment Goals in Axial Spondyloarthritis: A Story About Dysbiosis or Just a Matter of Bias?

por Queiro-Silva, Rubén, García-Valle, Andrea, Alonso-Castro, Sara, Alperi-López, Mercedes
Publicado 2021

Interleukin-17–targeted treatment in patients with spondyloarthritis and associated cardiometabolic risk profile

por Queiro, Rubén, Aurrecoechea, Elena, Alonso Castro, Sara, Villa Blanco, Ignacio, Brandy-Garcia, Anahy, Linge, Raquel
Publicado 2023

Differentiated Effect of Smoking on Disease Activity and Quality of Life among Different Spondyloarthritis Phenotypes

por Alonso-Castro, Sara, García-Valle, Andrea, Morante-Bolado, Isla, Braña, Ignacio, Pardo, Estefanía, Queiro, Rubén
Publicado 2023